GlassScriptPhysician profile
Karla T Timms
NPI 1962838698
$1,416.62
in general payments reported to CMS, 2019-2025
14 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $14.90 · 2023: $433 · 2024: $172 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $265.83 | 2023-2024 | Andexxa |
| Acera Surgical, INC. | $233.78 | 2023-2025 | Restrata Wound Matrix |
| Misonix INC | $211.33 | 2021 | |
| Octapharma USA, INC. | $206.11 | 2025 | Fibryga |
| Vertex Pharmaceuticals Incorporated | $116.98 | 2025 | |
| Davol INC. | $88.76 | 2021 | |
| Avanos Medical | $72.31 | 2023 | On-Q* Pump and Accessories |
| Coloplast Corp | $65.94 | 2024 | |
| Smith+Nephew, INC. | $40.31 | 2025 | Stravix Pl |
| Avita Medical Americas, LLC | $36.56 | 2025 | Cohealyx, Recell, Permeaderm |
| Polynovo North America LLC | $25.33 | 2024 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $21.65 | 2025 | |
| Lungpacer Medical USA INC | $16.83 | 2025 | Aeropace Neurostimulation Console |
| Trevena, INC. | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Timms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.